BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20117257)

  • 21. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.
    Yang M; Trettel LB; Adams DJ; Harrison JR; Canalis E; Kream BE
    Bone; 2010 Sep; 47(3):573-82. PubMed ID: 20541046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the SH3BP2 gene mutation in cherubism.
    Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
    Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
    Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
    J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jawing about TNF: new hope for cherubism.
    Novack DV; Faccio R
    Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
    Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
    Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.
    Kittaka M; Yoshimoto T; Schlosser C; Rottapel R; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2020 Feb; 35(2):382-395. PubMed ID: 31613396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commensal Microbiota Enhance Both Osteoclast and Osteoblast Activities.
    Uchida Y; Irie K; Fukuhara D; Kataoka K; Hattori T; Ono M; Ekuni D; Kubota S; Morita M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29937485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone.
    Dvorak MM; Chen TH; Orwoll B; Garvey C; Chang W; Bikle DD; Shoback DM
    Endocrinology; 2007 Jul; 148(7):3156-63. PubMed ID: 17412806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
    Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
    J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of the SH3BP2 gene in 2 families of cherubism.
    Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
    Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
    Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
    Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
    Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
    PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development.
    Robinson LJ; Mancarella S; Songsawad D; Tourkova IL; Barnett JB; Gill DL; Soboloff J; Blair HC
    Lab Invest; 2012 Jul; 92(7):1071-83. PubMed ID: 22546867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic overexpression of ephrin b1 in bone cells promotes bone formation and an anabolic response to mechanical loading in mice.
    Cheng S; Kesavan C; Mohan S; Qin X; Alarcon CM; Wergedal J; Xing W
    PLoS One; 2013; 8(7):e69051. PubMed ID: 23874863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.
    Vinik Y; Shatz-Azoulay H; Vivanti A; Hever N; Levy Y; Karmona R; Brumfeld V; Baraghithy S; Attar-Lamdar M; Boura-Halfon S; Bab I; Zick Y
    Elife; 2015 May; 4():e05914. PubMed ID: 25955862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone dynamics and inflammation: lessons from rare diseases.
    Matsumoto Y; Rottapel R
    Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
    Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
    Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy.
    Zhu K; Yi J; Xiao Y; Lai Y; Song P; Zheng W; Jiao H; Fan J; Wu C; Chen D; Zhou J; Xiao G
    J Biol Chem; 2015 Mar; 290(13):8081-94. PubMed ID: 25648889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.